High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study Group
Top Cited Papers
- 1 December 2003
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (23) , 4386-4394
- https://doi.org/10.1200/jco.2003.11.059
Abstract
Purpose: We present an update of a previously reported Late Effects Study Group cohort of 1,380 children with Hodgkin’s disease (HD) diagnosed between 1955 and 1986 in patients aged 16 years or younger. We describe the pattern and incidence of subsequent neoplasms (SNs) occurring with extended follow-up. Patients and Methods: Median age at diagnosis of HD was 11.7 years (range, 0.3 to 16.9 years) and at last follow-up was 27.8 years. Median length of follow-up was 17.0 years. Results: An additional 103 SNs were ascertained (total SNs = 212). The cohort was at an 18.5-fold increased risk of developing SNs compared with the general population (standardized incidence ratio [SIR], 18.5, 95% CI, 15.6 to 21.7). The cumulative incidence of any second malignancy was 10.6% at 20 years, increasing to 26.3% at 30 years; and of solid malignancies was 7.3% at 20 years, increasing to 23.5% at 30 years. Breast cancer was the most common solid malignancy (SIR, 56.7). Other commonly occurring solid malignancies included thyroid cancer (SIR, 36.4), bone tumors (SIR, 37.1), and colorectal (SIR, 36.4), lung (SIR, 27.3), and gastric cancers (SIR, 63.9). Risk factors for solid tumors included young age at HD and radiation-based therapy. Thirty-two patients developed third neoplasms, with the cumulative incidence approaching 21% at 10 years from diagnosis of second malignancy. Conclusion: Additional follow-up of this large cohort of HD survivors documents an increasing occurrence of known radiation-associated solid tumors, (breast and thyroid cancers), as well as emergence of epithelial neoplasms common in adults, (colon and lung cancers) at a younger age than expected in the general population, necessitating ongoing surveillance of this high risk population.Keywords
This publication has 42 references indexed in Scilit:
- Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 YearsJournal of Clinical Oncology, 2002
- VAMP and Low-Dose, Involved-Field Radiation for Children and Adolescents With Favorable, Early-Stage Hodgkin’s Disease: Results of a Prospective Clinical TrialJournal of Clinical Oncology, 2002
- Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor StudyJNCI Journal of the National Cancer Institute, 2001
- Second Cancers Among Long-Term Survivors of Hodgkin’s Disease Diagnosed in Childhood and AdolescenceJournal of Clinical Oncology, 2000
- Second cancers following pediatric Hodgkin's disease.Journal of Clinical Oncology, 1998
- Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology.Journal of Clinical Oncology, 1996
- Stage I and II Hodgkin's Disease in the Pediatric PopulationAmerican Journal of Clinical Oncology, 1996
- Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's DiseaseNew England Journal of Medicine, 1996
- Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.Journal of Clinical Oncology, 1995
- ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.Journal of Clinical Oncology, 1994